Cumulative Burden of Mental Health Factors and Engagement in HIV Care in Argentina.

Argentina Comorbidities HIV South America

Journal

International journal of behavioral medicine
ISSN: 1532-7558
Titre abrégé: Int J Behav Med
Pays: England
ID NLM: 9421097

Informations de publication

Date de publication:
Jun 2021
Historique:
pubmed: 30 7 2020
medline: 30 7 2020
entrez: 30 7 2020
Statut: ppublish

Résumé

Cumulative burden of multiple mental health conditions may worsen physical health outcomes in vulnerable populations. Accordingly, identifying cumulative burdens of mental health conditions that may affect HIV treatment and care can guide public health strategies to reduce their impact on HIV-related health outcomes. This study examined the relationship between the cumulative burden of mental health conditions and factors associated with engagement in HIV care in Argentina. Data for this study was obtained at baseline from Conexiones y Opciones Positivas en la Argentina 2 (COPA2). Participants (N = 360) were cisgender patients living with HIV who were lost to care, recruited from seven clinics serving people living with HIV in four Argentine urban centers. Cumulative burden of mental health conditions (i.e., depressive symptoms, problematic substance use, unhealthy alcohol use, and psychotic symptoms) was assessed. Every one-point increase in the number of mental health conditions present was associated with a decrement in patient-provider communication (b = - 0.22, p < .001), self-efficacy (b = - 0.13, p = .012), and motivation for adherence (b = - 0.11, p = .039). This study found cumulative burden of depression, problematic substance use, unhealthy alcohol use, and psychotic symptoms to be negatively associated with factors related to engagement in HIV care. Results highlight the importance of identification and treatment of challenges to mental health, in order to ameliorate their influence on engagement in HIV care.

Sections du résumé

BACKGROUND BACKGROUND
Cumulative burden of multiple mental health conditions may worsen physical health outcomes in vulnerable populations. Accordingly, identifying cumulative burdens of mental health conditions that may affect HIV treatment and care can guide public health strategies to reduce their impact on HIV-related health outcomes. This study examined the relationship between the cumulative burden of mental health conditions and factors associated with engagement in HIV care in Argentina.
METHOD METHODS
Data for this study was obtained at baseline from Conexiones y Opciones Positivas en la Argentina 2 (COPA2). Participants (N = 360) were cisgender patients living with HIV who were lost to care, recruited from seven clinics serving people living with HIV in four Argentine urban centers. Cumulative burden of mental health conditions (i.e., depressive symptoms, problematic substance use, unhealthy alcohol use, and psychotic symptoms) was assessed.
RESULTS RESULTS
Every one-point increase in the number of mental health conditions present was associated with a decrement in patient-provider communication (b = - 0.22, p < .001), self-efficacy (b = - 0.13, p = .012), and motivation for adherence (b = - 0.11, p = .039).
CONCLUSION CONCLUSIONS
This study found cumulative burden of depression, problematic substance use, unhealthy alcohol use, and psychotic symptoms to be negatively associated with factors related to engagement in HIV care. Results highlight the importance of identification and treatment of challenges to mental health, in order to ameliorate their influence on engagement in HIV care.

Identifiants

pubmed: 32725586
doi: 10.1007/s12529-020-09921-5
pii: 10.1007/s12529-020-09921-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

318-327

Subventions

Organisme : NIMH NIH HHS
ID : R01MH110242
Pays : United States
Organisme : NIH HHS
ID : P30AI07396
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH110242
Pays : United States
Organisme : NIH HHS
ID : P30AI07396
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Ministerio de Salud y Desarrollo Social. Boletín sobre el VIH, sida e ITS en la Argentina. Dirección de Sida E, Hepatitis y TBC; 2019.
UNAIDS. 90–90–90 - an ambitious treatment target to help end the AIDS epidemic. 2014.
Ministerio de Salud y Desarrollo Social. Boletín sobre el VIH, sida e ITS en la Argentina. Dirección de Sida E, Hepatitis y TBC; 2018.
Sued O, Cassetti I, Cecchini D, Cahn P, de Murillo LB, Weiss SM, et al. Physician-delivered motivational interviewing to improve adherence and retention in care among challenging HIV-infected patients in Argentina (COPA2): study protocol for a cluster randomized controlled trial. Trials. 2018;19(1):396.
De Boni RB, Shepherd BE, Grinsztejn B, et al. Substance use and adherence among people living with HIV/AIDS receiving cART in Latin America. AIDS Behav. 2016;20(11):2692–9. https://doi.org/10.1007/s10461-016-1398-6 .
doi: 10.1007/s10461-016-1398-6 pubmed: 27091028 pmcid: 5069110
Jones DL, Sued O, Cecchini D, Bofill L, Cook R, Lucas M, et al. Improving adherence to care among “hard to reach” HIV-infected patients in Argentina. AIDS Behav. 2016;20(5):987–97. https://doi.org/10.1007/s10461-015-1133-8 .
doi: 10.1007/s10461-015-1133-8 pubmed: 26152608 pmcid: 4706505
Blank MB, Himelhoch S, Walkup J, Eisenberg MM. Treatment considerations for HIV-infected individuals with severe mental illness. Curr HIV/AIDS Rep. 2013;10(4):371–9. https://doi.org/10.1007/s11904-013-0179-3 .
doi: 10.1007/s11904-013-0179-3 pubmed: 24158425
Walkup J, Blank MB, Gonzalez JS, Safren S, Schwartz R, Brown L, et al. The impact of mental health and substance abuse factors on HIV prevention and treatment. J Acquir Immune Defic Syndr. 2008;47(Suppl 1):S15–9. https://doi.org/10.1097/QAI.0b013e3181605b26 .
doi: 10.1097/QAI.0b013e3181605b26 pubmed: 18301129
Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7. https://doi.org/10.1097/QAI.0b013e31822d490a .
doi: 10.1097/QAI.0b013e31822d490a pubmed: 21857529
Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet. 2017;389(10072):941–50. https://doi.org/10.1016/S0140-6736(17)30003-X .
doi: 10.1016/S0140-6736(17)30003-X pubmed: 28271845
Mwangi C, Karanja S, Gachohi J, Wanjihia V, Ngang’a Z. Depression, injecting drug use, and risky sexual behavior syndemic among women who inject drugs in Kenya: a cross-sectional survey. Harm Reduct J. 2019;16(1):35. https://doi.org/10.1186/s12954-019-0307-5 .
doi: 10.1186/s12954-019-0307-5 pubmed: 31146748 pmcid: 6543607
Teixeira da Silva D, Bouris A, Voisin D, Hotton A, Brewer R, Schneider J. Social networks moderate the syndemic effect of psychosocial and structural factors on HIV risk among young Black transgender women and men who have sex with men. AIDS BEHAV. 2019. https://doi.org/10.1007/s10461-019-02575-9
Biello KB, Colby D, Closson E, Mimiaga MJ. The syndemic condition of psychosocial problems and HIV risk among male sex workers in Ho Chi Minh City, Vietnam. AIDS Behav. 2014;18(7):1264–71. https://doi.org/10.1007/s10461-013-0632-8 .
doi: 10.1007/s10461-013-0632-8 pubmed: 24081899 pmcid: 4363106
Herrick A, Stall R, Egan J, Schrager S, Kipke M. Pathways towards risk: syndemic conditions mediate the effect of adversity on HIV risk behaviors among young men who have sex with men (YMSM). J Urban Health: Bullet New York Acad Med. 2014;91(5):969–82. https://doi.org/10.1007/s11524-014-9896-1 .
doi: 10.1007/s11524-014-9896-1
Senn TE, Carey MP, Vanable PA. The intersection of violence, substance use, depression, and STDs: testing of a syndemic pattern among patients attending an urban STD clinic. J Natl Med Assoc. 2010;102(7):614–20. https://doi.org/10.1016/s0027-9684(15)30639-8 .
doi: 10.1016/s0027-9684(15)30639-8 pubmed: 20690325
Harkness A, Bainter SA, O’Cleirigh C, Albright C, Mayer KH, Safren SA. Longitudinal effects of syndemics on HIV-positive sexual minority men’s sexual health behaviors. Arch Sex Behav. 2019;48(4):1159–70. https://doi.org/10.1007/s10508-018-1329-x .
doi: 10.1007/s10508-018-1329-x pubmed: 30868437 pmcid: 6586562
Glynn TR, Safren SA, Carrico AW, et al. High levels of syndemics and their association with adherence, viral non-suppression, and biobehavioral transmission risk in Miami, a U.S. city with an HIV/AIDS epidemic. AIDS Behav. 2019. https://doi.org/10.1007/s10461-019-02619-0 .
Blashill AJ, Bedoya CA, Mayer KH, O’Cleirigh C, Pinkston MM, Remmert JE, et al. Psychosocial syndemics are additively associated with worse ART adherence in HIV-infected individuals. AIDS Behav. 2015;19(6):981–6. https://doi.org/10.1007/s10461-014-0925-6 .
doi: 10.1007/s10461-014-0925-6 pubmed: 25331267 pmcid: 4405426
Friedman MR, Stall R, Silvestre AJ, Wei C, Shoptaw S, Herrick A, et al. Effects of syndemics on HIV viral load and medication adherence in the multicentre AIDS cohort study. AIDS. 2015;29(9):1087–96. https://doi.org/10.1097/QAD.0000000000000657 .
doi: 10.1097/QAD.0000000000000657 pubmed: 25870981
Harkness A, Bainter SA, O’Cleirigh C, Mendez NA, Mayer KH, Safren SA. Longitudinal effects of syndemics on ART non-adherence among sexual minority men. AIDS Behav. 2018;22(8):2564–74. https://doi.org/10.1007/s10461-018-2180-8 .
doi: 10.1007/s10461-018-2180-8 pubmed: 29860556 pmcid: 6628710
Garcia de Olalla P, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, Cayla JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;30(1):105–10. https://doi.org/10.1097/00042560-200205010-00014 .
doi: 10.1097/00042560-200205010-00014 pubmed: 12048370
Dombrowski JC, Kitahata MM, Van Rompaey SE, et al. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. J Acquir Immune Defic Syndr. 2013;63(3):299–306. https://doi.org/10.1097/QAI.0b013e3182945bc7 .
doi: 10.1097/QAI.0b013e3182945bc7 pubmed: 23572013 pmcid: 3691075
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. https://doi.org/10.1016/j.jbi.2008.08.010 .
doi: 10.1016/j.jbi.2008.08.010 pubmed: 18929686 pmcid: 18929686
Beck AT, Steer RA. Manual for the Beck Depression Inventory. San Antonio: Psychological Corporation; 1993.
Bonicatto S, Dew AM, Soria JJ. Analysis of the psychometric properties of the Spanish version of the Beck Depression Inventory in Argentina. Psychiatry Res. 1998;79(3):277–85. https://doi.org/10.1016/s0165-1781(98)00047-x .
doi: 10.1016/s0165-1781(98)00047-x pubmed: 9704874
Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abus Treat. 2007;32(2):189–98. https://doi.org/10.1016/j.jsat.2006.08.002 .
doi: 10.1016/j.jsat.2006.08.002
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption--II. Addiction. 1993;88(6):791–804. https://doi.org/10.1111/j.1360-0443.1993.tb02093.x .
doi: 10.1111/j.1360-0443.1993.tb02093.x pubmed: 8329970 pmcid: 8329970
Cohen MA, Gorman JM, Letendre SL, Jacobson JM, Volberding P. Comprehensive textbook of AIDS psychiatry: a paradigm for integrated care. New York: Oxford University Press; 2017.
doi: 10.1093/med/9780199392742.001.0001
Malta M, Todd CS, Stibich MA, Garcia T, Pacheco D, Bastos FI. Patient–provider communication and reproductive health among HIV-positive women in Rio de Janeiro, Brazil. Patient Educ Couns. 2010;81(3):476–82.
doi: 10.1016/j.pec.2010.09.013
Remien RH, Dolezal C, Wagner GJ, Goggin K, Wilson IB, Gross R, et al. The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as prevention. AIDS Behav. 2014;18(8):1541–7.
doi: 10.1007/s10461-013-0656-0
Ekstrand ML, Chandy S, Heylen E, Steward W, Singh G. Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study. J Acquir Immune Defic Syndr. 2010;53(3):415–6. https://doi.org/10.1097/QAI.0b013e3181ba3e4e .
doi: 10.1097/QAI.0b013e3181ba3e4e pubmed: 20190588 pmcid: 2831235
Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES). J Behav Med. 2007;30(5):359–70. https://doi.org/10.1007/s10865-007-9118-3 .
doi: 10.1007/s10865-007-9118-3 pubmed: 17588200 pmcid: 2423379
The LifeWindows Project Team. The LifeWindows Information Motivation Behavioral Skills ART Adherence Questionnaire (LW-IMB-AAQ). Storrs: Center for Health, Intervention, and Prevention, University of Connecticut; 2006.
Sullivan KA, Messer LC, Quinlivan EB. Substance abuse, violence, and HIV/AIDS (SAVA) syndemic effects on viral suppression among HIV positive women of color. AIDS Patient Care STDs. 2015;29(Suppl 1):S42–8. https://doi.org/10.1089/apc.2014.0278 .
doi: 10.1089/apc.2014.0278 pubmed: 25397666 pmcid: 4283071
Rodriguez VJ, Sued O, Cecchini D, Mandell LN, Bofill LM, Weiss SM, et al. Suicidality among nonadherent patients living with HIV in Buenos Aires, Argentina: prevalence and correlates. AIDS Care. 2018;30(11):1380–7. https://doi.org/10.1080/09540121.2018.1458974 .
doi: 10.1080/09540121.2018.1458974 pubmed: 29607661 pmcid: 6150832
Jones D, Cook R, Cecchini D, Sued O, Bofill L, Weiss S, et al. Examining adherence among challenging patients in public and private HIV care in Argentina. AIDS Behav. 2015;19(9):1619–29. https://doi.org/10.1007/s10461-015-1037-7 .
doi: 10.1007/s10461-015-1037-7 pubmed: 25777507 pmcid: 4553072
de Moraes RP, Casseb J. Depression and adherence to antiretroviral treatment in HIV-positive men in Sao Paulo, the largest city in South America: social and psychological implications. Clin (Sao Paulo). 2017;72(12):743–9. https://doi.org/10.6061/clinics/2017(12)05 .
doi: 10.6061/clinics/2017(12)05
Bulsara SM, Wainberg ML, Newton-John TRO. Predictors of adult retention in HIV care: a systematic review. AIDS Behav. 2018;22(3):752–64. https://doi.org/10.1007/s10461-016-1644-y .
doi: 10.1007/s10461-016-1644-y pubmed: 27990582 pmcid: 5476508
Bofill LM, Lopez M, Dorigo A, Bordato A, Lucas M, Cabanillas GF, et al. Patient-provider perceptions on engagement in HIV care in Argentina. AIDS Care. 2014;26(5):602–7. https://doi.org/10.1080/09540121.2013.844767 .
doi: 10.1080/09540121.2013.844767 pubmed: 24138788
Prevention Access Campaign. Risk of sexual transmission of HIV from a person living with HIV who has an undetectable viral load: Messaging Primer & Consensus Statement. 2019. https://www.preventionaccess.org/consensus . Accessed 26 Sept 2019.

Auteurs

Omar Sued (O)

Fundacion Huesped, Buenos Aires, Argentina. omar.sued@huesped.org.ar.

Diego Cecchini (D)

Hospital General de Agudos Dr. Cosme Argerich, Buenos Aires, Argentina.
Helios Salud, Buenos Aires, Argentina.

John M Abbamonte (JM)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.

Violeta J Rodriguez (VJ)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Department of Psychology, University of Georgia, Athens, GA, USA.

Lissa N Mandell (LN)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.

Nicholas V Cristofari (NV)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.

Maria Inés Figueroa (MI)

Fundacion Huesped, Buenos Aires, Argentina.

Isabel Cassetti (I)

Helios Salud, Buenos Aires, Argentina.

Pedro Cahn (P)

Fundacion Huesped, Buenos Aires, Argentina.

Stephen M Weiss (SM)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.

Maria L Alcaide (ML)

Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.

Florencia Cahn (F)

Centro Medico Huésped, Buenos Aires, Argentina.

Liliana Calanni (L)

CEIN Unidad Infectologica, Neuquén, Argentina.

Ana Crinejo (A)

Hospital Guillermo Rawson, Córdoba, Argentina.

Daniel David (D)

Hospital Guillermo Rawson, Córdoba, Argentina.

Sergio Lupo (S)

Instituto Centralizado de Asistencia e Investigación Clínica Integral (CAICI), Rosario, Argentina.

Carolina Pérez (C)

Centro Medico Huésped, Buenos Aires, Argentina.

Rufina Pérez (R)

CEIN Unidad Infectologica, Neuquén, Argentina.

Claudia Rodriguez (C)

Hospital General de Agudos Dr. Cosme Argerich, Buenos Aires, Argentina.

María José Rolón (MJ)

Hospital General de Agudos Dr. Juan A. Fernández, Buenos Aires, Argentina.

Alicia Sisto (A)

Hospital General de Agudos Dr. Juan A. Fernández, Buenos Aires, Argentina.

Liliana Trapé (L)

Instituto Centralizado de Asistencia e Investigación Clínica Integral (CAICI), Rosario, Argentina.

Deborah L Jones (DL)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.

Classifications MeSH